Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maison de l’Artemisia is a French non-profit organization dedicated to the study and distribution of Artemisia annua and Artemisia afra as sustainable, local treatments for malaria. The organization focuses on establishing a network of "Maisons" across endemic regions, particularly in Africa, to promote the cultivation and use of these medicinal plants. By conducting clinical research and advocating for herbal medicine, the association aims to provide an affordable and accessible alternative to conventional antimalarial drugs. Their work encompasses agricultural training, scientific validation, and community health education to combat the global malaria burden.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maison de l’Artemisia.